TearClear

United States
Panora, Iowa, United States

Company profile

TearClear company profile

TearClear is a pharmaceutical company that specializes in providing a class platform of drugs that enables medication delivery to ultimately enhance patient safety and compliance by capturing preservatives before they reach the ocular surface. Founded in 2015, TearClear is headquartered in California, United States.

Business identity

Phone number
617-454-7251
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2015-12-15

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
6
Total equity funding
$43.3M
Last funding
Series Unknown / $11.8M / 2023-07-11
Last equity funding
Series Unknown / $11.8M
Investors
3
Lead investors
2
Founders
5
Articles
13

Founders and investors

Founders

Anuj ChauhanKen BantaKevin I. HershfieldRichard HeinickWilliam Grappi

Lead investors

Bluestem CapitalVisionary Venture Fund

Investors

Bluestem CapitalFlying L PartnersVisionary Venture Fund